These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30063579)

  • 1. CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH STEROID ENEMA.
    Peiris TJ; El Rami HE; Sun JK
    Retin Cases Brief Rep; 2021 Jan; 15(1):15-17. PubMed ID: 30063579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Serous Chorioretinopathy.
    Daruich A; Matet A; Behar-Cohen F
    Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.
    Prakash G; Shephali J; Tirupati N; Ji PD
    Middle East Afr J Ophthalmol; 2013; 20(4):363-5. PubMed ID: 24339692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant.
    Noh GM; Nam KY; Lee SU; Lee SJ
    Korean J Ophthalmol; 2019 Aug; 33(4):392-394. PubMed ID: 31389218
    [No Abstract]   [Full Text] [Related]  

  • 6. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreoretinal Lymphoma Masquerading as Central Serous Chorioretinopathy.
    Sadhar B; Yarkoni AG; Patel KK; Mantopoulos D; Milman T; Shields CL; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2024 Aug; 55(8):467-470. PubMed ID: 38752916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY.
    Han J; Cho NS; Kim K; Kim ES; Kim DG; Kim JM; Yu SY
    Retina; 2020 Jul; 40(7):1387-1394. PubMed ID: 31157711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effect of corticosteroid therapy: Central serous chorioretinopathy.
    Geoffroy M; Afriat M; Fauconier M; Eschard JP; Salmon JH
    Joint Bone Spine; 2018 Jan; 85(1):127-128. PubMed ID: 28219658
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
    Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J
    Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELONGATED PHOTORECEPTOR OUTER SEGMENT LENGTH AND PROGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Asano KS; Asaoka R; Asano S; Azuma K; Inoue T; Obata R
    Retina; 2020 Apr; 40(4):750-757. PubMed ID: 30640283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; MacLaren RE; Querques G; Fauser S; Hoyng CB; Downes SM; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1419-1425. PubMed ID: 31123815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy.
    Değirmenci C; Afrashi F; Nalçacı S; Çeper SB
    Turk J Ophthalmol; 2019 Dec; 49(6):367-369. PubMed ID: 31893595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
    Chung YR; Kim JW; Song JH; Park A; Kim MH
    Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection.
    Lee SB; Kim JY; Kim WJ; Cho CB; Iwase T; Jo YJ
    Indian J Ophthalmol; 2013 Sep; 61(9):514-5. PubMed ID: 24104712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central serous chorioretinopathy and achromatopsia: a case report.
    Mahmoudi A; Berijani S; Bazvand F; Adelpour F; Khojasteh H
    Doc Ophthalmol; 2020 Dec; 141(3):307-312. PubMed ID: 32424630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY.
    van Dijk EHC; Schellevis RL; Breukink MB; Mohabati D; Dijkman G; Keunen JEE; Yzer S; den Hollander AI; Hoyng CB; de Jong EK; Boon CJF
    Retina; 2019 Feb; 39(2):398-407. PubMed ID: 29190234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.